- New alliance will crack down on adulterated products touting dietary supplement claims
- Adherence among chronic disease patients can lead to big savings
- FDA limits amount of acetaminophen in prescription drugs
- FDA releases annual 'Generic Drug Roundup'
- FDA approves test to monitor levels of Zortress in the bloodstream
DUBLIN — The Food and Drug Administration has approved a new strength of an antibiotic made by Warner Chilcott, the drug maker said.
Warner Chilcott announced the approval of the 200-mg strength of Doryx (doxycycline hyalite) delayed-release tablets, which the company plans to release in July 2013.
Doryx delayed-release tablets are already available in the 75-mg, 100-mg and 150-mg strengths.